- Home
- RZLT vs DSM Comparison
RZLT vs DSM Comparison
Compare RZLT & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- DSM
- Stock Information
- Founded
- RZLT 2010
- DSM 1989
- Country
- RZLT United States
- DSM United States
- Employees
- RZLT N/A
- DSM N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- DSM Investment Managers
- Sector
- RZLT Health Care
- DSM Finance
- Exchange
- RZLT Nasdaq
- DSM Nasdaq
- Market Cap
- RZLT 292.0M
- DSM 303.5M
- IPO Year
- RZLT N/A
- DSM N/A
- Fundamental
- Price
- RZLT $5.10
- DSM $6.15
- Analyst Decision
- RZLT Strong Buy
- DSM
- Analyst Count
- RZLT 8
- DSM 0
- Target Price
- RZLT $11.63
- DSM N/A
- AVG Volume (30 Days)
- RZLT 361.7K
- DSM 161.7K
- Earning Date
- RZLT 11-07-2024
- DSM 01-01-0001
- Dividend Yield
- RZLT N/A
- DSM 3.97%
- EPS Growth
- RZLT N/A
- DSM N/A
- EPS
- RZLT N/A
- DSM N/A
- Revenue
- RZLT N/A
- DSM N/A
- Revenue This Year
- RZLT N/A
- DSM N/A
- Revenue Next Year
- RZLT N/A
- DSM N/A
- P/E Ratio
- RZLT N/A
- DSM N/A
- Revenue Growth
- RZLT N/A
- DSM N/A
- 52 Week Low
- RZLT $0.76
- DSM $4.69
- 52 Week High
- RZLT $6.19
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- RZLT 50.30
- DSM 61.23
- Support Level
- RZLT $4.70
- DSM $6.00
- Resistance Level
- RZLT $5.14
- DSM $6.04
- Average True Range (ATR)
- RZLT 0.34
- DSM 0.05
- MACD
- RZLT -0.04
- DSM 0.02
- Stochastic Oscillator
- RZLT 37.45
- DSM 92.86
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.